MMP9 and infection: However, clarithromycin has been observed to reduce the inflammation caused by infection and decrease vascular hyperpermeability by suppressing the induction of matrix metalloproteinases-9 (MMP-9) and monocyte chemoattractant protein-1 (MCP-1) [19, 47].